Literature DB >> 29510821

German Pregnancy Register "Rhekiss".

Ulf Müller-Ladner, Rebecca Fischer-Betz.   

Abstract

Mesh：

Year:  2018        PMID： 29510821      PMCID： PMC5842343          DOI： 10.3238/arztebl.2018.0112a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  3 in total

1.  The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

Authors:  Carina Götestam Skorpen; Maria Hoeltzenbein; Angela Tincani; Rebecca Fischer-Betz; Elisabeth Elefant; Christina Chambers; Josè da Silva; Catherine Nelson-Piercy; Irene Cetin; Nathalie Costedoat-Chalumeau; Radboud Dolhain; Frauke Förger; Munther Khamashta; Guillermo Ruiz-Irastorza; Angela Zink; Jiri Vencovsky; Maurizio Cutolo; Nele Caeyers; Claudia Zumbühl; Monika Østensen
Journal:  Ann Rheum Dis       Date:  2016-02-17       Impact factor: 19.103

2.  The Treatment of Illnesses Arising in Pregnancy.

Authors:  Michael Bolz; Sabine Körber; Toralf Reimer; Johannes Buchmann; Hans-Christof Schober; Volker Briese
Journal:  Dtsch Arztebl Int       Date:  2017-09-15       Impact factor: 5.594

3.  EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Authors:  L Andreoli; G K Bertsias; N Agmon-Levin; S Brown; R Cervera; N Costedoat-Chalumeau; A Doria; R Fischer-Betz; F Forger; M F Moraes-Fontes; M Khamashta; J King; A Lojacono; F Marchiori; P L Meroni; M Mosca; M Motta; M Ostensen; C Pamfil; L Raio; M Schneider; E Svenungsson; M Tektonidou; S Yavuz; D Boumpas; A Tincani
Journal:  Ann Rheum Dis       Date:  2016-07-25       Impact factor: 19.103
  3 in total
  1 in total

Review 1.  [Regional cooperative rheumatology centers : Networking of rheumatology in Germany for over 25 years].

Authors:  B Gundelach; C Specker
Journal:  Z Rheumatol       Date:  2020-12-01       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.